Among the general US population, simple and affordable non-invasive liver fibrosis scoring systems may be able to identify individuals at risk for HF.

The growing emphasis on advanced liver fibrosis treatments highlights a paradigm shift in addressing chronic liver diseases, ...

Steatotic liver disease affects approximately one tenth of lean adults in the United States, according to data from the ...

Hepatic fibrosis is the common result of injury to the liver from a variety of damaging mechanisms, and the accurate assessment of the degree of fibrosis is clinically important. For many years ...

The following is a summary of “Association between the triglyceride-glucose index and liver fibrosis in adults with metabolism-related fatty liver disease in the United States: a cross-sectional study ...

The health problem comes in four stages ― steatosis, where a harmless level of fat is deposited in the liver; steatohepatitis ...

The therapy showed a ‘favourable’ safety profile both as a single agent and in combination with standard-of-care treatment.

All chronic liver diseases can lead to fibrosis and cirrhosis, but the progression timeline varies greatly from person to person. Some stay at the simple fatty liver stage, while others go through ...

Liver siRNA is under clinical development by Nitto BioPharma and currently in Phase II for Liver Cancer. According to GlobalData, Phase II drugs for Liver Cancer have a 31% phase transition success ...

Ozempic is well-known for its ability to manage type 2 diabetes and aid weight loss. . But as more research emerges, additional health benefits of the GLP-1 drug are being uncovered. Previous studies ...